|
1357
|
SD 169
|
MAPK inhibitor (p38α specific) |
€60.00 |
|
1387
|
SD 208
|
TGF-βR 1 inhibitor |
€50.00 |
|
1265
|
SDZ-WAG 994
|
Adenosine A1 agonist |
€125.00 |
|
2751
|
SEA0400
|
Inhibitor of Na+/Ca2+ exchanger (NCX) |
€135.00 |
|
2605
|
Selexipag
|
Prodrug of MRE 269, a potent IP receptor (PGI2) agonist |
€90.00 |
|
1956
|
Selisistat
|
Potent and selective SIRT1 inhibitor |
€90.00 |
|
2956
|
Selonsertib
|
Potent, highly selective, orally available, and ATP-competitive ASK1 inhibitor |
€90.00 |
|
3195
|
Selpercatinib
|
Potent, highly selective, and ATP-competitive RET inhibitor |
€110.00 |
|
2524
|
Sephin 1
|
Selective PPP1R15A inhibitor devoid of PPP1R15B and α2-adrenergic activity |
€55.00 |
|
1447
|
Seratrodast
|
Thromboxane A2 antagonist |
€85.00 |
|
1141
|
Sertindole
|
5-HT2, D2 and α1 adrenoceptor antagonist |
€82.00 |
|
1300
|
Sertraline hydrochloride
|
SSRI; Antidepressant |
€85.00 |
|
1672
|
SEW 2871
|
S1PR1 agonist |
€75.00 |
|
2186
|
SF 1670
|
Inhibitor of PTEN with significant inhibitory effect on PTPRC and GALK |
€120.00 |
|
3395
|
SGC-STK17B-1
|
Potent, selective and ATP-competitive STK17B inhibitor |
€95.00 |